MedTrace Logo

Finding New Targets by Proteomic Approaches (InnovRT1)

NCT04868799 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2025-11-20

No results posted yet for this study

Summary

The investigators aim to explore the inter tumor heterogeneity by a proteomic approach of a wide series of rhabdoid tumors, from both intra and extra cranial origins.

Conditions

  • ATRT

Interventions

BIOLOGICAL

Mass spectrometry

Characterization of the proteomic and phosphoproteomic landscape using mass spectrometry

Sponsors & Collaborators

  • Institut Curie

    collaborator OTHER

  • Sainte Anne hospital

    collaborator UNKNOWN

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Kevin Beccaria, MD, PhD · APHP Assistance Publique des Hôpitaux de Paris

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-12
Primary Completion
2023-02-17
Completion
2023-02-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04868799 on ClinicalTrials.gov